Evidence map›Paper›PMID 30567290›Full record

ArticleInternational journal of molecular sciences2018

Molecular Mechanisms and Pathophysiology of Ischemia-Reperfusion Injury.

Arnau Panisello-Roselló, Joan Roselló-Catafau

Open access · goldAbstract readEditorial
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. The Development of Novel Drug Treatments for Stroke Patients: A Review.International journal of molecular sciences · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arnau Panisello-RosellóIschemia-Reperfusion Unit, Experimental Pathology Department, Institut d'Insvestigacions Biomèdiques de Barcelona (IIBB), Spanish Research Council, 08036 Barcelona, Catalonia, Spain. arnau.panisello.rosello@gmail.com.ORCID 0000-0003-2062-6134
Joan Roselló-CatafauIschemia-Reperfusion Unit, Experimental Pathology Department, Institut d'Insvestigacions Biomèdiques de Barcelona (IIBB), Spanish Research Council, 08036 Barcelona, Catalonia, Spain. jrcbam@iibb.csic.es.
Institut d'Investigacions Biomèdiques de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion injury (IRI) is a major cause of graft loss and dysfunction in clinical transplantation and organ resection. [...].

Indexed as

ApoptosisGraft RejectionHumansLiver TransplantationNitric OxideProto-Oncogene Proteins c-aktReperfusion InjurySignal TransductionTOR Serine-Threonine KinasesNitric OxideProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinases

Identifiers

PMID30567290
PMCPMC6321148
OpenAlexW2905417259

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.